How should I manage a child with Pseudomonas sepsis, including initial fluid resuscitation, empiric anti‑pseudomonal antibiotic therapy, source control, and supportive care?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Pseudomonas Sepsis in Children

Administer anti-pseudomonal antibiotics within 1 hour of recognizing septic shock, begin aggressive fluid resuscitation with 20 mL/kg isotonic crystalloid boluses up to 40-60 mL/kg in the first hour, and initiate vasopressor support early if shock persists despite adequate fluid administration. 1

Immediate Resuscitation (0-15 Minutes)

Airway and Breathing

  • Provide high-flow oxygen via face mask, high-flow nasal cannula, or nasopharyngeal CPAP to maintain SpO₂ >90% 1
  • Secure peripheral IV or intraosseous access immediately for fluid and medication administration 1
  • Perform cardiovascular resuscitation before intubation if mechanical ventilation is needed, as this reduces hemodynamic instability during the procedure 1

Initial Fluid Resuscitation

  • Administer 20 mL/kg boluses of isotonic crystalloid (normal saline or balanced solution) over 5-10 minutes, repeating up to 40-60 mL/kg total in the first hour 1
  • Titrate fluid administration to clinical endpoints: capillary refill ≤2 seconds, normal blood pressure for age, warm extremities, urine output ≥1 mL/kg/hr, normal mental status, and no differential between peripheral and central pulses 1
  • Stop fluid boluses immediately if hepatomegaly or rales develop—these indicate fluid overload and mandate inotropic support rather than additional fluids 1

Metabolic Correction

  • Check and correct hypoglycemia and hypocalcemia immediately 1

Anti-Pseudomonal Antibiotic Therapy (Within 1 Hour)

Empiric Coverage

  • Obtain blood cultures before antibiotics when possible, but never delay antibiotic administration beyond 1 hour to obtain cultures 1
  • Administer broad-spectrum anti-pseudomonal beta-lactam antibiotics within 1 hour of septic shock recognition—each hour of delay increases mortality 2, 3
  • Recommended empiric regimens for Pseudomonas coverage include:
    • Ceftazidime 50 mg/kg IV every 8 hours (max 2 g/dose), OR
    • Piperacillin-tazobactam 100 mg/kg IV every 6-8 hours (max 4.5 g/dose), OR
    • Meropenem 20-40 mg/kg IV every 8 hours (max 2 g/dose) 2
  • Add aminoglycoside (gentamicin 7.5 mg/kg IV once daily or tobramycin 7.5 mg/kg IV once daily) for synergy in severe Pseudomonas septic shock 1
  • Consider adding vancomycin 15 mg/kg IV every 6 hours if MRSA co-infection is suspected (recent ICU stay, indwelling devices) 2

Hemodynamic Support (15-60 Minutes)

Fluid-Refractory Shock

  • Begin peripheral inotropic support if central venous access is not yet available in children who remain hypotensive after 40-60 mL/kg fluid resuscitation 1
  • Obtain central venous access and secure airway as needed 1

Vasopressor/Inotrope Selection Based on Shock Phenotype

For "cold shock" (cold extremities, delayed capillary refill, normal or elevated blood pressure):

  • Titrate central dopamine 5-10 mcg/kg/min, OR
  • If dopamine-resistant, titrate central epinephrine 0.05-0.3 mcg/kg/min 1

For "warm shock" (warm extremities, bounding pulses, low blood pressure):

  • Titrate central norepinephrine 0.05-0.3 mcg/kg/min 1

Catecholamine-Resistant Shock (After 60 Minutes)

  • Administer hydrocortisone 2 mg/kg IV (max 100 mg) if at risk for absolute adrenal insufficiency and shock persists despite adequate fluid and catecholamines 1
  • Monitor central venous pressure (CVP) and target normal MAP-CVP with ScvO₂ ≥70% 1
  • Target hemoglobin ≥10 g/dL during active resuscitation if ScvO₂ <70% 1

For cold shock with normal blood pressure:

  • Add vasodilator therapy (nitrosovasodilators or milrinone) with volume loading if ScvO₂ remains <70% 1

For cold shock with low blood pressure:

  • Consider adding norepinephrine if ScvO₂ <70% despite epinephrine 1

For warm shock with low blood pressure:

  • Consider vasopressin, terlipressin, or angiotensin if hypotension persists 1

Refractory Shock

  • Evaluate for and reverse pneumothorax, pericardial tamponade, or endocrine emergencies 1
  • Consider ECMO for refractory pediatric septic shock 1

Source Control

  • Identify and control the infection source as soon as possible—inadequate source control synergistically increases mortality 1
  • Perform emergent imaging (ultrasound, CT) to identify abscesses, empyema, necrotizing pneumonia, or other drainable foci 1
  • Debride necrotizing fasciitis or gangrenous myonecrosis urgently 1
  • Remove infected intravascular devices after establishing alternative access 1

Ongoing Monitoring and Supportive Care

Hemodynamic Targets

  • Maintain MAP appropriate for age, capillary refill ≤2 seconds, urine output ≥1 mL/kg/hr, normal mental status, and cardiac index 3.3-6.0 L/min/m² 1
  • Monitor serial lactate levels to guide resuscitation toward normalization 2, 4

Mechanical Ventilation (If Required)

  • Use lung-protective strategies: tidal volume 6 mL/kg predicted body weight, plateau pressure ≤30 cm H₂O 1, 3
  • Maintain head-of-bed elevation 30-45° 1

Glycemic Control

  • Target glucose <180 mg/dL; provide glucose infusion with insulin therapy in neonates and children (some are insulin-deficient, others insulin-resistant) 1, 3

Fluid Overload Management

  • Use diuretics to reverse fluid overload once shock has resolved; if unsuccessful, initiate continuous venovenous hemofiltration or intermittent dialysis to prevent >10% total body weight fluid overload 1, 3

Nutrition

  • Begin enteral nutrition as soon as hemodynamically stable; provide parenteral nutrition if enteral feeding is not tolerated 1, 3

Sedation and Drug Monitoring

  • Use sedation with a defined goal in mechanically ventilated patients 1
  • Monitor drug toxicity levels closely because drug metabolism is reduced in severe sepsis, increasing the risk of adverse drug events 1, 3

Antimicrobial Stewardship

  • Reassess antibiotic therapy daily once pathogen identification and susceptibilities are available, typically within 48-72 hours 2, 4, 3
  • Narrow to the most appropriate single agent (e.g., ceftazidime or cefepime monotherapy) within 3-5 days based on culture results and clinical improvement 2, 4
  • Plan a total antibiotic course of 7-10 days for most Pseudomonas infections; extend duration for slow clinical response, undrained foci, or immunodeficiency 2, 4

Common Pitfalls

  • Do not delay antibiotics to obtain cultures—blood cultures should be drawn rapidly, but antibiotic administration must occur within 1 hour regardless 1
  • Do not continue fluid boluses if hepatomegaly or rales develop—this indicates fluid overload and requires immediate transition to inotropic support 1
  • Do not use dopamine as first-line therapy in warm shock—norepinephrine is the preferred vasopressor for distributive (warm) shock 1
  • Do not assume all pediatric septic shock is "cold shock"—assess perfusion phenotype (cold vs. warm) to guide vasopressor/inotrope selection 1
  • Do not overlook source control—failure to drain abscesses or remove infected devices is independently associated with increased mortality 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Septic Shock in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Initial Management of Pediatric Viral Sepsis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Sepsis Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.